$0.6655
0.022.38%
At close: -
$0.6403
-0.03-3.79%
After Hours: 7:23 PM EDT
NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.60 | $-0.30 | -100.0 % |
Q2 | 2024-08-13 | $-1.37 | $-1.23 | -11.4 % |
Q1 | 2024-05-09 | $-4.90 | $-5.25 | 6.67 % |
Q4 | 2024-03-26 | $-7.35 | $-10.50 | 30.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $2.44M | $2.62M | -6.94 % |
Q2 | 2024-08-13 | $2.40M | $3.15M | -23.8 % |
Q1 | 2024-05-09 | $2.63M | $3.28M | -19.8 % |
Q4 | 2024-03-26 | $3.73M | $3.40M | 9.62 % |
NovaBay Pharmaceuticals (NBY) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.60, which missed the estimate of $-0.30.
The Actual Revenue was $2.4M, which missed the estimate of $2.6M.
Browse earnings estimates, EPS, and revenue on all stocks.